Nunes M, Bartosch C, Abreu M, Richardson A, Almeida R, Ricardo S
    
    
    Cells. 2024; 13(9.
  
  
    PMID: 38727322
    
          PMC: 11083313.
    
          DOI: 10.3390/cells13090786.
      
 
                                  
  
    Cao J, Zhang Z, Zhou L, Luo M, Li L, Li B
    
    
    MedComm (2020). 2023; 4(6):e427.
  
  
    PMID: 38045829
    
          PMC: 10693315.
    
          DOI: 10.1002/mco2.427.
      
 
                                  
  
    Wang S, Teng Q, Wang S, Lei Z, Hu H, Lv H
    
    
    Acta Pharm Sin B. 2022; 12(8):3263-3280.
  
  
    PMID: 35967279
    
          PMC: 9366537.
    
          DOI: 10.1016/j.apsb.2022.03.023.
      
 
                                  
  
    Pape V, Palko R, Toth S, Szabo M, Sessler J, Dorman G
    
    
    J Med Chem. 2022; 65(11):7729-7745.
  
  
    PMID: 35613553
    
          PMC: 9189845.
    
          DOI: 10.1021/acs.jmedchem.2c00076.
      
 
                                  
  
    Yang Q, Guo X, Xu Y, Duan C, Wang H, Feng Q
    
    
    Transl Cancer Res. 2022; 10(1):10-21.
  
  
    PMID: 35116235
    
          PMC: 8797790.
    
          DOI: 10.21037/tcr-20-2678.
      
 
                              
              
                              
                                      
  Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer.
  
    Gu M, He T, Yuan Y, Duan S, Li X, Shen C
    
    
    Front Oncol. 2021; 11:753386.
  
  
    PMID: 34900703
    
          PMC: 8662819.
    
          DOI: 10.3389/fonc.2021.753386.
      
 
                                          
                                                          
  Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?.
  
    Mollaei M, Hassan Z, Khorshidi F, Langroudi L
    
    
    Transl Oncol. 2021; 14(5):101056.
  
  
    PMID: 33684837
    
          PMC: 7938256.
    
          DOI: 10.1016/j.tranon.2021.101056.
      
 
                                          
                                                          
  Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells.
  
    Pape V, Gaal A, Szatmari I, Kucsma N, Szoboszlai N, Streli C
    
    
    Cancers (Basel). 2021; 13(1).
  
  
    PMID: 33466433
    
          PMC: 7796460.
    
          DOI: 10.3390/cancers13010154.
      
 
                                          
                                                          
  Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
  
    Zhong J, Zhang J, Yu X, Zhang X, Dian L
    
    
    Med Sci Monit. 2020; 26:e924922.
  
  
    PMID: 32830792
    
          PMC: 7466836.
    
          DOI: 10.12659/MSM.924922.
      
 
                                          
                                                          
  Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme.
  
    Vagiannis D, Novotna E, Skarka A, Kammerer S, Kupper J, Chen S
    
    
    Cancers (Basel). 2020; 12(4).
  
  
    PMID: 32231067
    
          PMC: 7226045.
    
          DOI: 10.3390/cancers12040813.
      
 
                                          
                                                          
  Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery.
  
    Nagarajan N, Yapp E, Le N, Kamaraj B, Al-Subaie A, Yeh H
    
    
    Biomed Res Int. 2019; 2019:8427042.
  
  
    PMID: 31886259
    
          PMC: 6925679.
    
          DOI: 10.1155/2019/8427042.
      
 
                                          
                                                          
  Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
  
    Zhang Y, Wang Y, Lei Z, Zhang G, Zhang X, Wang D
    
    
    Cancer Lett. 2018; 442:104-112.
  
  
    PMID: 30392788
    
          PMC: 8148022.
    
          DOI: 10.1016/j.canlet.2018.10.032.
      
 
                                          
                                                          
  Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
  
    Vera A, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q
    
    
    Cancer Lett. 2018; 442:91-103.
  
  
    PMID: 30391357
    
          PMC: 6348084.
    
          DOI: 10.1016/j.canlet.2018.10.020.
      
 
                                          
                                                          
  ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?.
  
    Adamska A, Falasca M
    
    
    World J Gastroenterol. 2018; 24(29):3222-3238.
  
  
    PMID: 30090003
    
          PMC: 6079284.
    
          DOI: 10.3748/wjg.v24.i29.3222.
      
 
                                          
                                                          
  The challenge of drug resistance in cancer treatment: a current overview.
  
    Nikolaou M, Pavlopoulou A, Georgakilas A, Kyrodimos E
    
    
    Clin Exp Metastasis. 2018; 35(4):309-318.
  
  
    PMID: 29799080
    
    
          DOI: 10.1007/s10585-018-9903-0.
      
 
                                          
                                                          
  ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.
  
    Davis Jr W, Tew K
    
    
    Biochem Pharmacol. 2017; 151:188-200.
  
  
    PMID: 29223352
    
          PMC: 5899931.
    
          DOI: 10.1016/j.bcp.2017.11.018.
      
 
                                          
                                                          
  Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.
  
    Manandhar S, Kim C, Lee S, Kang S, Basnet N, Lee Y
    
    
    Oncotarget. 2017; 8(41):70521-70537.
  
  
    PMID: 29050299
    
          PMC: 5642574.
    
          DOI: 10.18632/oncotarget.19737.
      
 
                                          
                                                          
  Effect of praziquantel on the differential expression of mouse hepatic genes and parasite ATP binding cassette transporter gene family members during Schistosoma mansoni infection.
  
    Sanchez M, Krasnec K, Parra A, von Cabanlong C, Gobert G, Umylny B
    
    
    PLoS Negl Trop Dis. 2017; 11(6):e0005691.
  
  
    PMID: 28650976
    
          PMC: 5501684.
    
          DOI: 10.1371/journal.pntd.0005691.
      
 
                                          
                                                          
  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.
  
    Mbaveng A, Kuete V, Efferth T
    
    
    Front Pharmacol. 2017; 8:343.
  
  
    PMID: 28626426
    
          PMC: 5454075.
    
          DOI: 10.3389/fphar.2017.00343.
      
 
                                          
                                                          
  Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein.
  
    Esser L, Shukla S, Zhou F, Ambudkar S, Xia D
    
    
    Acta Crystallogr F Struct Biol Commun. 2016; 72(Pt 8):636-41.
  
  
    PMID: 27487928
    
          PMC: 4973305.
    
          DOI: 10.1107/S2053230X16009778.